about
Dysferlin quantification in monocytes for rapid screening for dysferlinopathiesAssociation of vWA and TPOX polymorphisms with venous thrombosis in Mexican mestizos.Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain.Genetic analysis of 17 Y-STRs in a Mestizo population from the Central Valley of Mexico.Interethnic variation of the MMP-9 microsatellite in Amerindian and Mexican Mestizo populations: considerations for genetic association studies.Nanoparticulate strategies for the treatment of polyglutamine diseases by halting the protein aggregation process.Spinocerebellar ataxia type 7: a neurodegenerative disorder with peripheral neuropathy.Association of the calcitonin gene (CA) polymorphism with osteoarthritis of the knee in a Mexican mestizo population.Origin of the myotonic dystrophy type 1 mutation in Mexican population and influence of Amerindian ancestry on CTG repeat allelic distribution.Recessive spinocerebellar ataxia with paroxysmal cough attacks: a report of five cases.Dopaminergic denervation switches dopamine D3 receptor signaling and disrupts its Ca(2+) dependent modulation by CaMKII and calmodulin in striatonigral projections of the rat.Origin of the spinocerebellar ataxia type 7 gene mutation in Mexican population.Voice Alterations in Patients With Spinocerebellar Ataxia Type 7 (SCA7): Clinical-Genetic Correlations.Association of interleukin-6 gene polymorphisms with bone mineral density in Mexican women.Comprehensive mapping of human body skin hydration: A pilot studyAssociation of the estrogen receptor α gene polymorphisms with osteoporosis in the Mexican populationThe intracellular domain of β-dystroglycan mediates the nucleolar stress response by suppressing UBF transcriptional activityAssociation of the CT gene (CA) polymorphism with BMD in osteoporotic Mexican womenThe relationship among IL-13, GSTP1, and CYP1A1 polymorphisms and environmental tobacco smoke in a population of children with asthma in Northern MexicoA comprehensive clinical and genetic study of a large Mexican population with spinocerebellar ataxia type 7Analysis of CAG repeats in five SCA loci in Mexican population: epidemiological evidence of a SCA7 founder effectFrom traditional biochemical signals to molecular markers for detection of sepsis after burn injuriesOxidative Stress in Spinocerebellar Ataxia Type 7 Is Associated with Disease SeverityFounder Effects of Spinocerebellar Ataxias in the American Continents and the CaribbeanEffect of UV and Gamma Irradiation Sterilization Processes in the Properties of Different Polymeric Nanoparticles for Biomedical ApplicationsAltered Plasma Acylcarnitines and Amino Acids Profile in Spinocerebellar Ataxia Type 7Non-invasive methods for evaluation of skin manifestations in patients with ichthyosisNon-invasive analysis of skin mechanical properties in patients with lamellar ichthyosisEffects of Physical Rehabilitation in Patients with Spinocerebellar Ataxia Type 7Wide Profiling of Circulating MicroRNAs in Spinocerebellar Ataxia Type 7Enhanced nuclear protein export in premature aging and rescue of the progeria phenotype by modulation of CRM1 activityDevelopment and Evaluation of Alginate Membranes with Curcumin-Loaded Nanoparticles for Potential Wound-Healing ApplicationsNew copolymers as hosts of ribosomal RNAOropharyngeal dysphagia in early stages of myotonic dystrophy type 1
P50
Q30144043-9045A531-D7B7-4F54-A616-05F75B53A829Q34181424-1A503957-5AB1-4DF3-982C-E920B69AB69CQ38363236-40887148-9BC1-4DD7-94C8-8E0E8DBA7C82Q38470377-D9030A35-D551-4565-8642-626EBAB7407AQ39018701-5BF310FC-23DB-4895-8AE7-EC82347B5EFCQ39112084-A1807E43-5A2D-4754-A245-269B0B06CAF8Q41539905-4FC298E3-F2C4-45CD-90C8-9A26787FBACBQ43279876-07321290-D211-4AA7-A3F6-235E5DF2C753Q47751826-EF9D0104-7EC4-4050-A4B3-2BFBCBA44488Q48151660-F3BAC0B5-A0D2-4A60-8349-270A9B29B7CAQ48409318-692EAF70-3C98-472F-AC99-8607E2E7DE5EQ50857368-2844092D-6BAA-4A04-98E0-740C109083D3Q53145378-90BC73C5-0018-42BE-8EDA-1AFE127C1034Q54522526-4D840406-E3BB-497D-B959-DE8E6CEDADA5Q57286636-EFBA15D7-DC7E-489F-8A4F-545F9F04474BQ60563377-9B2DDE1B-11DB-4FE7-AB15-0CE5A54C52D8Q64094178-735E929C-1DE3-42B8-8B0A-631E040D5389Q79205786-9E5D5571-78C7-4074-B39C-4B75103FB060Q83212030-FE8717C3-D8BD-4F00-AAFE-7B2E10E1C295Q85797469-7E993CEC-71F6-4B7F-9D71-9832B6548089Q86027978-C1801880-A1DA-4E92-8F96-9AAEEEBABFA7Q88866347-4AA1ED29-6BBE-47C4-9A64-257A240120A6Q89017853-29016416-8F18-4C0B-956D-4CD027B73736Q89839203-A2FAFF1C-F598-4EF3-A9D8-9E3A16D924F3Q89978059-720A4039-B460-4AD1-92FC-135C933817D4Q90073266-FE2EA57C-4FD3-4906-9372-56BE342B8DA1Q90785391-5C02BEAD-BA9F-4F6C-820D-5373F2BC1A77Q90845711-C244AC24-B0CB-406A-98A0-C1A6F6AD7D5FQ91285302-F75E9155-2FD3-4411-8966-9C8FCF44B5C1Q91352865-B6436231-6C19-4268-AA21-004FCEC76562Q91874490-81DF236A-7AA2-4A10-84B2-681427C0988BQ92422237-393D5CD2-999F-4256-92DB-55F65D600E8EQ92437762-64D67F62-FC94-4B9F-A642-B79AC4E65091Q93148689-8A325B75-E704-4280-AD6B-79FD61E18DA1
P50
description
researcher ORCID ID=0000-0003-4399-4618
@en
wetenschapper
@nl
name
Jonathan J. Magaña
@en
Jonathan J. Magaña
@nl
type
label
Jonathan J. Magaña
@en
Jonathan J. Magaña
@nl
altLabel
Magaña JJ
@en
prefLabel
Jonathan J. Magaña
@en
Jonathan J. Magaña
@nl
P106
P31
P496
0000-0003-4399-4618